The immunogenicity and safety of different formulations of a novel Staphylococcus aureus vaccine (V710): Results of two Phase I studies

► V710 is a S. aureus vaccine containing the highly conserved IsdB surface protein. ► V710 was immunogenic in healthy subjects in a liquid, adjuvanted vaccine. ► V710 was immunogenic in healthy subjects in a lyophilized vaccine. ► All formulations were immunogenic within 14 days in healthy subjects. ► All formulations were well-tolerated.